German Committee Prognosis Raises Pharma Hopes On Price Cap, Rebate
This article was originally published in The Pink Sheet Daily
Executive Summary
The positive financial prognosis for German health insurers might prompt the government to look at removing the drug price rise moratorium and obligatory rebate.